Discontinuation report HUMATROPE

Last updated on 2024-10-18 History
Report ID 240679
Drug Identification Number 02243078
Brand name HUMATROPE
Common or Proper name somatropin for injection
Company Name ELI LILLY CANADA INC
Market Status MARKETED
Active Ingredient(s) SOMATROPIN DILUENT
Strength(s) 12MG 3.15ML
Dosage form(s) POWDER FOR SOLUTION LIQUID
Route of administration SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR
Packaging size Combination package containing 12 mg humatrope sterile lyophilized powder in a 3.5 mL cartridge and 3.15 mL prefilled diluent syringe
ATC code H01AC
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2025-12-31
Actual discontinuation date
Remaining supply date 2025-12-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply Anticipated remaining supply date may be impacted based on any changes in demand.
Company comments For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments
Tier 3 Status No
Contact Address EXCHANGE TOWER, 130 KING STREET WEST
TORONTO, ONTARIO
CANADA M5X 1B1
Company contact information Lilly Canada’s Customer Response Centre 1-888-545-5972.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-10-18 French Compare
v1 2024-10-18 English Compare

Showing 1 to 2 of 2